Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases

Mostrar otras versiones (1)

OBJECTIVE: Osteoporosis (OP) can complicate the course of rheumatic musculoskeletal diseases (RMDs) and connective tissue diseases (CTDs). Denosumab, a monoclonal antibody against RANK-L, showed beneficial effect in rheumatoid arthritis in inhibiting radiographic progression and erosive burden. We t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruni, Cosimo, Cigolini, Cosimo, Tesei, Giulia, Cometi, Laura, Bartoli, Francesca, Fiori, Ginevra, Nacci, Francesca, Bellando-Randone, Silvia, Guiducci, Serena, Matucci-Cerinic, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Research and Education Association 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176229/
https://www.ncbi.nlm.nih.gov/pubmed/35110179
http://dx.doi.org/10.5152/eurjrheum.2020.21162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176229/
https://www.ncbi.nlm.nih.gov/pubmed/35110179
http://dx.doi.org/10.5152/eurjrheum.2020.21162

Ejemplares similares